Background. Patients with chronic kidney disease (CKD) are associated with increased cardiovascular morbidity and mortality. An increase in the ratio of pre-ejection period (PEP) to ejection time (ET) is correlated with an increase in left ventricular mass index (LVMI) and a decrease in left ventricular ejection fraction (LVEF). Brachial PEP (bPEP) and brachial ET (bET) can be automatically determined by an ankle-brachial index (ABI)-form device. The aims of this study were to assess whether bPEP/bET is a useful parameter in evaluation of LVMI and LVEF in patients with CKD and to evaluate the diagnostic value of bPEP/bET in the prediction of LVEF <50%. Methods. We consecutively enrolled 234 CKD patients from our Outpatient Department of Internal Medicine. Both bPEP and bET were measured using an ABI-form device. Clinical and echocardiographic parameters were compared and analysed. Results. Multivariate analysis results show that bPEP/bET, systolic blood pressure, and body mass index were positively while albumin was negatively associated with LVMI. In addition, increased bPEP/bET, coronary artery disease, decreased albumin, and increased triglyceride were independent factors associated with decreased LVEF. The area under the curve for bPEP/bET in the prediction of LVEF <50% was 0.859. Conclusions. Our findings show that bPEP/bET is an important determinant of LVMI and LVEF in CKD patients. It is also helpful in identification of CKD patients with LVEF < 50%. Screening CKD patients by means of bPEP/bET may help identify a high risk group of increased LVMI and decreased LVEF.
Introduction
Chronic kidney disease (CKD) is a worldwide public health problem with increasing burden globally [1, 2] . Development of cardiovascular disease is one major ominous outcome of CKD [3] . Structural and functional left ventricular abnormalities in CKD patients have been frequently noted. Patients with CKD have been reported to have a high prevalence of increased left ventricular mass index (LVMI) and decreased left ventricular systolic function [4, 5] . Both pressure and volume overloads can contribute to left ventricular geometric and functional abnormalities in CKD patients [4] . Furthermore, increased LVMI and decreased left ventricular systolic function have been reported to be significantly correlated with an increase of cardiovascular morbidity and mortality [6, 7] . Therefore, identifying patients with increased LVMI and decreased left ventricular systolic dysfunction for aggressive treatment interventions is important in managing patients with CKD.
Prolonged pre-ejection period (PEP) and shortened ejection time (ET) have been reported to be significantly correlated with decreased left ventricular systolic function [8] [9] [10] . Hence, the ratio of PEP to ET may enhance the diagnostic value for identification of left ventricular systolic dysfunction [8] . However, left ventricular systolic function is frequently evaluated using echocardiography, which may preclude its application if echocardiography or experienced operators are not available. A clinical device, ankle-brachial index (ABI)-form (Colin VP1000, Komaki, Japan), has been developed to automatically and simultaneously measure blood pressure in both arms and ankles and record pulse waves of the brachial and posterior tibial arteries using an automated oscillometric method. Using this device, we can easily and automatically calculate the brachial PEP (bPEP) and brachial ET (bET) by analysing the signals of electrocardiogram, phonocardiogram and brachial pressure volume waveform [11] . We have recently found that bPEP/bET has a significant correlation with left ventricular ejection fraction (LVEF) and LVMI and is a useful predictor for overall and cardiovascular mortality in patients with haemodialysis [12, 13] . Furthermore, we have reported that bPEP/ bET is also a useful predictor of cardiovascular events in CKD patients [14] . However, as yet, there has been no study validating the correlation between bPEP/bET and LVEF and LVMI in CKD patients. In addition, brachial-ankle pulse wave velocity (baPWV) could be obtained by the ABI-form device. It was reported to be a good parameter of arterial stiffness [15, 16] and has a negative correlation with LVMI, left ventricular volume index and LVEF [13, 17] . The aim of this study was to assess whether bPEP/bET and baPWV are useful parameters in evaluation of LVEF and LVMI in CKD patients.
Materials and methods

Study patients and design
The study was conducted in a regional hospital in southern Taiwan. Patients with atrial fibrillation and complete left bundle branch block were excluded. We consecutively enrolled 243 patients with CKD of stages 3 to 5 [18] from our Outpatient Department of Internal Medicine from July 2009 to February 2010. Nine patients with inadequate image visualization were excluded and a final total of 234 patients (mean age 63.5 ± 12.6 years, 154 males/80 females) were included. The protocol was approved by our Institutional Review Board and all enrolled patients gave written informed consent.
Assessment of bPEP, bET, ABI and baPWV
Both bPEP and bET were measured by an ABI-form device, which automatically and simultaneously measures blood pressure in both arms and ankles using an oscillometric method [11, 19] . The bET was automatically measured from the foot to the dicrotic notch (equivalent to the incisura on the downstroke of the aortic pressure wave contour produced by the closure of aortic valve) of the pulse volume waveform. The total electromechanical systolic interval (QS 2 ) was measured from the onset of the QRS complex on the electrocardiogram to the first high-frequency vibration of the aortic component of the second heart sound on the phonocardiogram. The bPEP was also automatically calculated by subtracting the bET from the QS 2 ( Figure 1 ). The ABI and baPWV values were also measured, and the measurement method has been reported and validated in previous studies [11, 19, 20] .
Collection of demographic, medical and laboratory data
Demographic and medical data including age, gender, smoking history (ever versus never) and comorbid conditions were obtained from medical records and interviews with patients. The body mass index (BMI) was calculated as the ratio of weight in kilograms divided by square of height in metres. Laboratory data were measured from fasting blood samples using an autoanalyser (COBAS Integra 400; Roche Diagnostics GmbH, Mannheim, Germany). Estimated glomerular filtration rate (eGFR) was calculated using the simplified formula in Modification of Diet in Renal Disease study [21] . Proteinuria was examined by dipsticks (Hema-Combistix, Bayer Diagnostics). A test result of 1+ or more was defined as positive. Blood and urine samples were obtained within 1 month of enrollment.
Evaluation of cardiac structure and function Study patients received echocardiographic examination within 1 week of bPEP/bET measurement. The echocardiographic examination was performed by the same experienced sonographer using transthoracic echocardiography (Vivid 7; General Electric Medical Systems, Horten, Norway), with the participant respiring quietly in the left decubitus position. Twodimensional and two-dimensionally guided M-mode images were recorded from the standardized views. Left ventricular mass was calculated using the Devereux-modified method [22] . LVMI was calculated by dividing left ventricular mass by body surface area. Left ventricular systolic function was assessed by LVEF.
Statistical analysis
Statistical analysis was performed using SPSS 12.0 for Windows (SPSS Inc. Chicago, USA). Data are expressed as percentages or mean ± standard deviation. The differences between groups were checked by independent t-test for continuous variables. The relationship between two continuous variables was assessed by a bivariate correlation method (Pearson's correlation). Age, gender and the significant variables in the univariate analysis were selected for stepwise multiple linear regression analysis. Multiple logistic regression was employed to identify the risk factors associated with LVEF <50%. Receiver operating characteristic (ROC) curve was constructed for the prediction of LVEF <50%. A difference was considered significant if the P-value was <0.05.
Results
The clinical characteristics of study patients are shown in Table 1 . There were 143 (61.1%), 46 (19.7%) and 45 Table 2 shows the determinants of LVMI in our study patients. The LVMI correlated positively with male, presence of hypertension, systolic blood pressure, diastolic blood pressure, pulse pressure, BMI, bPEP/bET and proteinuria but negatively with serum albumin level and eGFR. Further stepwise multivariate analysis shows that increased LVMI was correlated with increased systolic blood pressure, increased BMI, increased bPEP/bET and decreased serum albumin level. Figure 2 shows the regression plot between bPEP/bET and LVMI (r = 0.363, P < 0.001). Table 3 shows the determinants of LVEF in our study patients. The LVEF correlated negatively with bPEP/bET. Decreased LVEF had also a significant correlation with male sex, smoking, presence of coronary artery disease, increased diastolic blood pressure, increased heart rate, decreased serum albumin level and increased triglyceride level. In the stepwise multivariate analysis, serum albumin level was positively while bPEP/bET, coronary artery disease and triglyceride were negatively associated with LVEF. Figure 3 illustrates the regression plot between bPEP/bET and LVEF (r = −0.445, P < 0.001).
The abnormally high value of ABI might be related to poor arterial compressibility resulting from stiffness and calcification; therefore, we excluded six patients with ABI > 1.3 and analysed the remaining 228 patients and found similar results, i.e. LVMI was significantly correlated with systolic blood pressure (β = 0.252, P < 0.001), BMI (β = 0.177, P = 0.006), bPEP/bET (β = 0.251, P < 0.001) and albumin (β = −0.155, P = 0.024). Additionally, LVEF was significantly correlated with coronary artery disease (β = −0.181, P = 0.006), bPEP/bET (β = −0.295, P < 0.001), albumin (β = 0.256, P < 0.001) and triglyceride (β = −0.143, P = 0.032). Table 4 shows the determinants of LVEF <50% among study patients. In the univariate regression analysis, LVEF <50% was found to be significantly associated with decreased age, a history of coronary artery disease, increased diastolic blood pressure, increased heart rate, increased bPEP/bET and decreased serum albumin level. We performed two multivariate analyses. In the first multivariate analysis (model 1: covariates included age, gender, presence of coronary artery disease, diastolic blood pressure, heart rate and serum albumin level; − 2 log likelihood: 109.367, Nagelkerke R square: 0.385), presence of coronary artery disease [odds ratio (OR), 9.704; P < 0.001], increased heart rate (OR, 1.041; P = 0.043) and decreased serum albumin level (OR, 0.078; P < 0.001) were independent risk factors for LVEF <50%. In the second multivariate analysis (model 2: covariates included age, gender, presence of coronary artery disease, diastolic blood pressure, heart rate, bPEP/bET and serum albumin level; − 2 log likelihood: 89.739, Nagelkerke R square: 0.520), presence of coronary artery disease (OR, 11.093; P < 0.001) and bPEP/bET (OR, 1.171; P < 0.001) were positively while serum albumin level (OR, 0.069; P = 0.001) was negatively associated with LVEF <50%. The difference in likelihood ratio between these two models was 19.628 (P < 0.05), indicating that the additional variable, bPEP/ bET, could significantly increase the predictive power for LVEF <50%.
The prevalence of LVEF <50% was 13.7%. The bPEP/ bET was significantly higher in patients with depressed left ventricular systolic function (LVEF <50%) than in those with preserved left ventricular systolic function (LVEF > 50%) (0.47 ± 0.09 vs 0.35 ± 0.07, P < 0.001). The baPWV of patients with depressed and preserved left ventricular systolic function was comparable (1918.4 ± 662.7 vs 1898.7 ± 515.9 cm/s, P = 0.848). The ROC curves for bPEP/bET and baPWV in the prediction of LVEF <50% are shown in Figure 4 . The areas under the curve for bPEP/ bET and baPWV in the prediction of LVEF <50% are 0.859 and 0.480, respectively. In addition, we also calculated the statistical values of bPEP/bET >0.43, 0.42 and 0.40 and baPWV >1778, 1787 and 1732 cm/s in the prediction of LVEF <30%, 40% and 50% (Table 5) .
Discussion
In the present study, we determined the independent factors associated with LVMI and LVEF in patients with CKD. We found that bPEP/bET was an independent determinant of LVMI and LVEF and was helpful in the prediction of LVEF <50% in CKD patients. In addition, bPEP/bET could be obtained automatically and easily, so it might be helpful for large-scale screening in CKD patients to identify those with decreased left ventricular systolic function and increased LVMI.
Increased PEP and shortened ET were reported to be correlated with impaired left ventricular systolic function [8, 10] . Previous studies demonstrated that increased left ventricular mass might result in left ventricular dysfunction and, ultimately, congestive heart failure [23, 24] . Boudoulas et al. evaluated the relation between left ventricular mass and systolic performance in 90 patients with chronic systemic hypertension and found a significant correlation between increased PEP/ET and increased LVMI [25] . In the present study, we also found that bPEP/bET was independently and positively associated with LVMI but negatively associated with LVEF in CKD patients. This finding implies that CKD patients with increased bPEP/bET may be at high risk of increased LVMI and decreased left ventricular systolic function.
Previous studies have reported a relation between arterial stiffness and left ventricular systolic function [17, 26] . Wang et al. studied the relationship between arterial stiffness and cardiac remodelling in 96 CKD patients with mean LVEF of 74% and found that LVEF decreased gradually with progressive increase in aortic pulse wave velocity (PWV) [17] . Weber et al. also evaluated the relationship between aortic PWV and left ventricular systolic function in 63 patients with cardiomyopathy (LVEF <45%) and 126 controls (LVEF >50%). They found no difference in aortic PWV between cardiomyopathy patients and controls but a significant positive correlation between aortic PWV and LVEF in cardiomyopathy patients, thus concluding that aortic PWV was susceptible to left ventricular performance [26] . Therefore, the correlation between PWV and LVEF may be negative in patients with preserved left ventricular systolic function and positive in patients with depressed left ventricular systolic function. In the present study, patients with preserved and depressed left ventricular systolic function were both included, which might account for the absence of significant correlation between baPWV and LVEF in our patients. In addition, carotid-to-femoral PWV (cfPWV) reflects aortic PWV [27, 28] . In contrast, baPWV reflects a composite of several arterial segments, some of which are prone to arteriosclerosis alone (brachial and distal arteries) and some to both atherosclerosis and arteriosclerosis (aorta and femoral arteries). Therefore, baPWV may not be as reliable as cfPWV in reflecting aortic PWV. However, Tanaka et al. compared cfPWV and baPWV in 2287 patients and found a strong correlation between them (r = 0.73) [29] . Therefore, it was reasonable to use baPWV as a marker of arterial stiffness. However, the diagnostic values of baPWV in the prediction of decreased LVEF were low in the present study. Thus, bPEP/bET might not be a good marker in the prediction of patients with left ventricular systolic dysfunction. Inflammation and catabolism play a role in the pathophysiology of chronic heart failure [30, 31] . Malnutrition may worsen patient outcome by aggravating existing inflammation and heart failure and accelerating atherosclerosis [32] . Low serum albumin level has been regarded as malnutrition status. Hypoalbuminaemia has been reported to be associated with reduced LVEF and increased LVMI in patients with heart failure [33, 34] . Our results consistently demonstrated that decreased serum albumin level was independently associated with increased LVMI and decreased LVEF.
Age, gender, hypertension, diabetes and anaemia were reported to be correlated with LVMI [35, 36] . In the present 
Values expressed as standardized coefficient β. Abbreviations are same as Table 1 . Fig. 3 . Regression plot between the ratio of brachial pre-ejection period to brachial ejection time (bPEP/bET) and left ventricular ejection fraction (r = −0.445, P < 0.001).
bPEP/bET and LVEF and LVMI in CKD 1899 study, elevated systolic blood pressure was correlated with increased LVMI, which was consistent with the reported findings. In addition, previous studies demonstrated that obesity was linked with increased left ventricular mass and BMI was positively correlated with left ventricular and right ventricular mass and end-diastolic volume [37, 38] . The increase in LVMI in obese patients may be mainly caused by an increase in lean body mass, left ventricular stroke volume and visceral fat mass [38] . The BMI was also correlated with LVMI in our study patients. Left ventricular systolic dysfunction in patients with coronary artery disease may be caused by a localized infarction, scattered fibrosis or ischaemic noncontractile myocardium [39, 40] . Dyslipidaemia may also adversely influence left ventricular systolic function through its atherogenic effect on coronary circulation, resulting in restriction of coronary blood flow and the subsequent development of hibernating myocardium. Large-scale clinical trials have also shown that long-term prevention with lipid-lowering therapy led to a reduction in the occurrence of heart failure, suggesting that dyslipidaemia may have an adverse effect on left ventricular systolic function [41, 42] . Our study revealed that the presence of coronary artery disease and increased serum triglyceride level were independently associated with decreased LVEF, which is consistent with previous findings.
Falsely elevated pressures or incompressible arteries at ankle level are common among patients with extensive vascular calcification of the lower extremities, which may occur in patients with diabetes or chronic renal failure Covariates in model 1 included age, gender, presence of coronary artery disease, diastolic blood pressure, heart rate and serum albumin levels (−2 log likelihood: 109.367; Nagelkerke R square: 0.385). Covariates in model 2 included age, gender, presence of coronary artery disease, diastolic blood pressure, heart rate, bPEP/bET and serum albumin levels (−2 log likelihood: 89.739; Nagelkerke R square: 0.520). Fig. 4 . ROC curves for the ratio of brachial pre-ejection period to brachial ejection time (bPEP/bET) and brachial-ankle pulse wave velocity (baPWV) in the prediction of left ventricular ejection fraction <50%. [43, 44] . The abnormally high ABI value had been interpreted as the presence of medial arterial calcification [45] . Therefore, we performed a subgroup analysis after excluding six cases with ABI >1.3 and found that bPEP/ bET was still the determinants of LVMI and LVEF. Cardiac dysfunction portends a poor prognosis in renal failure [46] ; hence, assessment of heart function in patients with CKD is important. Although bPEP/bET can provide a simple and cheap method for detecting patients at risk of LVEF <50% and increased LVMI, it cannot completely replace echocardiography. Echocardiography can yield important additional information, such as valve function, valve calcification, left ventricular diastolic function and regional left ventricular wall motion.
Our study has several limitations. It was a cross-sectional study; therefore, the predictors of cardiovascular events could not be evaluated. Complete left bundle branch block can delay the closure of aortic valve and thus prolong QS 2 , so bPEP/bET can be affected by this conduction disturbance. Moreover, the measurement of bPEP and bET during atrial fibrillation is difficult because of beat-to-beat variation. Therefore, we excluded patients with complete left bundle branch block and atrial fibrillation. Hence, our results could not be applied in these patients. Finally, we did not assess whether bPEP/bET could alter with effective interventions. Further study is needed to validate this issue.
Conclusion
In conclusion, our results demonstrate that increased bPEP/bET had a significant correlation with increased LVMI and decreased LVEF in patients with CKD. In addition, bPEP/bET was useful in the prediction of CKD patients with LVEF < 50%. Screening CKD patients by means of bPEP/bET may help identify a high risk group of increased LVMI and decreased left ventricular systolic function.
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